{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T02:38:57Z","timestamp":1790995137060,"version":"4.1.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T00:00:00Z","timestamp":1588896000000},"content-version":"am","delay-in-days":342,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.autrev.2019.04.001","type":"journal-article","created":{"date-parts":[[2019,4,5]],"date-time":"2019-04-05T16:48:09Z","timestamp":1554482889000},"page":"621-626","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Corticosteroids and immunosuppressive agents for idiopathic recurrent pericarditis"],"prefix":"10.1016","volume":"18","author":[{"given":"Nathan","family":"Peiffer-Smadja","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanny","family":"Domont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Saadoun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrice","family":"Cacoub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"17","key":"10.1016\/j.autrev.2019.04.001_bb0005","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1001\/archinte.165.17.1987","article-title":"Colchicine as first-choice therapy for recurrent pericarditis: results of the CORE (COlchicine for REcurrent pericarditis) trial","volume":"165","author":"Imazio","year":"2005","journal-title":"Arch Intern Med sept"},{"issue":"9","key":"10.1016\/j.autrev.2019.04.001_bb0010","first-page":"290","article-title":"Colchicine for recurrent pericarditis (CORP) a randomized trial","author":"Arancibia","year":"2014","journal-title":"Ann Intern Med"},{"issue":"42","key":"10.1016\/j.autrev.2019.04.001_bb0015","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1093\/eurheartj\/ehv318","volume":"36","author":"Adler","year":"2015","journal-title":"Eur Heart J"},{"issue":"16","key":"10.1016\/j.autrev.2019.04.001_bb0020","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1056\/NEJMoa1208536","article-title":"A randomized trial of colchicine for acute pericarditis","volume":"369","author":"Imazio","year":"2013","journal-title":"N Engl J Med"},{"issue":"13","key":"10.1016\/j.autrev.2019.04.001_bb0025","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1161\/CIRCULATIONAHA.105.542738","article-title":"Colchicine in addition to conventional therapy for acute pericarditis: results of the COlchicine for acute PEricarditis (COPE) trial","volume":"112","author":"Imazio","year":"2005","journal-title":"Circulation."},{"issue":"9936","key":"10.1016\/j.autrev.2019.04.001_bb0030","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1016\/S0140-6736(13)62709-9","article-title":"Efficacy and safety of colchicine for treatment of multiple recurrences of pericarditis (CORP-2): a multicentre, double-blind, placebo-controlled, randomised trial","volume":"383","author":"Imazio","year":"2014","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.autrev.2019.04.001_bb0035","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1136\/hrt.2009.187138","article-title":"Anti-heart and anti-intercalated disk autoantibodies: evidence for autoimmunity in idiopathic recurrent acute pericarditis","volume":"96","author":"Caforio","year":"2010","journal-title":"Heart."},{"issue":"11","key":"10.1016\/j.autrev.2019.04.001_bb0040","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1586\/1744666X.2014.965150","article-title":"Idiopathic recurrent pericarditis as an immune-mediated disease: current insights into pathogenesis and emerging treatment options","volume":"10","author":"Imazio","year":"2014","journal-title":"Expert Rev Clin Immunol"},{"issue":"14","key":"10.1016\/j.autrev.2019.04.001_bb0045","first-page":"13","article-title":"Editorial - colchicine for treatment of acute or recurrent pericarditis","volume":"6736","author":"Cacoub","year":"2014","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.autrev.2019.04.001_bb0050","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.amjcard.2005.04.055","article-title":"Management, risk factors, and outcomes in recurrent pericarditis","volume":"96","author":"Imazio","year":"2005","journal-title":"Am J Cardiol"},{"issue":"7","key":"10.1016\/j.autrev.2019.04.001_bb0055","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1093\/eurheartj\/ehi197","article-title":"Pretreatment with corticosteroids attenuates the efficacy of colchicine in preventing recurrent pericarditis: a multi-Centre all-case analysis","volume":"26","author":"Artom","year":"2005","journal-title":"Eur Heart J"},{"issue":"6","key":"10.1016\/j.autrev.2019.04.001_bb0060","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1161\/CIRCULATIONAHA.107.761064","article-title":"Corticosteroids for recurrent pericarditis: high versus low doses: a nonrandomized observation","volume":"118","author":"Imazio","year":"2008","journal-title":"Circulation."},{"issue":"3","key":"10.1016\/j.autrev.2019.04.001_bb0065","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.ijcard.2011.01.027","article-title":"Azathioprine in isolated recurrent pericarditis: a single Centre experience","volume":"147","author":"Vianello","year":"2011","journal-title":"Int J Cardiol"},{"issue":"9","key":"10.1016\/j.autrev.2019.04.001_bb0070","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1016\/j.amjcard.2013.06.036","article-title":"Usefulness of high-dose intravenous human immunoglobulins treatment for refractory recurrent pericarditis","volume":"112","author":"Moretti","year":"2013","journal-title":"Am J Cardiol"},{"issue":"4","key":"10.1016\/j.autrev.2019.04.001_bb0075","doi-asserted-by":"crossref","first-page":"256","DOI":"10.2459\/JCM.0000000000000266","article-title":"Anakinra: an emerging option for refractory idiopathic recurrent pericarditis: a systematic review of published evidence","volume":"17","author":"Lazaros","year":"2016","journal-title":"J Cardiovasc Med Hagerstown Md avr"},{"issue":"18","key":"10.1016\/j.autrev.2019.04.001_bb0080","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1001\/jama.2016.15826","article-title":"Effect of Anakinra on recurrent pericarditis among patients with colchicine resistance and corticosteroid dependence: the AIRTRIP randomized clinical trial","volume":"316","author":"Brucato","year":"2016","journal-title":"JAMA"},{"issue":"8","key":"10.1016\/j.autrev.2019.04.001_bb0085","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/j.amjcard.2015.07.047","article-title":"Effectiveness and safety of Anakinra for Management of Refractory Pericarditis","volume":"116","author":"Jain","year":"2015","journal-title":"Am J Cardiol"},{"issue":"6","key":"10.1016\/j.autrev.2019.04.001_bb0090","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1016\/j.jpeds.2014.01.065","article-title":"Long-term efficacy of interleukin-1 receptor antagonist (anakinra) in corticosteroid-dependent and colchicine-resistant recurrent pericarditis","volume":"164","author":"Finetti","year":"2014","journal-title":"J Pediatr juin"},{"issue":"11","key":"10.1016\/j.autrev.2019.04.001_bb0095","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1016\/j.mayocp.2012.05.024","article-title":"Pericardiectomy vs medical management in patients with relapsing pericarditis","volume":"87","author":"Khandaker","year":"2012","journal-title":"Mayo Clin Proc"},{"issue":"8","key":"10.1016\/j.autrev.2019.04.001_bb0100","first-page":"CD010652","article-title":"Colchicine for pericarditis","author":"Alabed","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"issue":"42","key":"10.1016\/j.autrev.2019.04.001_bb0105","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1093\/eurheartj\/ehv318","article-title":"2015 ESC guidelines for the diagnosis and management of pericardial diseases","volume":"36","author":"Adler","year":"2015","journal-title":"Eur Heart J"},{"issue":"4","key":"10.1016\/j.autrev.2019.04.001_bb0110","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.ahj.2010.06.015","article-title":"International collaborative systematic review of controlled clinical trials on pharmacologic treatments for acute pericarditis and its recurrences","volume":"160","author":"Lotrionte","year":"2010","journal-title":"Am Heart J"},{"issue":"7","key":"10.1016\/j.autrev.2019.04.001_bb0115","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.amjcard.2004.06.046","article-title":"Recurrent pain without objective evidence of disease in patients with previous idiopathic or viral acute pericarditis","volume":"94","author":"Imazio","year":"2004","journal-title":"Am J Cardiol"},{"issue":"10","key":"10.1016\/j.autrev.2019.04.001_bb0120","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1345\/aph.1P294","article-title":"Intrapericardial triamcinolone administration for autoreactive pericarditis","volume":"44","author":"Frasiolas","year":"2010","journal-title":"Ann Pharmacother"},{"issue":"Box 2","key":"10.1016\/j.autrev.2019.04.001_bb0125","first-page":"99","article-title":"Recurrent pericarditis: new and emerging therapeutic options","volume":"13","author":"Imazio","year":"2015","journal-title":"Nat Rev Cardiol"},{"issue":"5","key":"10.1016\/j.autrev.2019.04.001_bb0130","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.amjcard.2015.12.012","article-title":"Usefulness of novel immunotherapeutic strategies for idiopathic recurrent pericarditis","volume":"117","author":"Lotan","year":"2016","journal-title":"Am J Cardiol"},{"issue":"5","key":"10.1016\/j.autrev.2019.04.001_bb0135","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.revmed.2016.12.006","article-title":"Recurrent pericarditis","volume":"38","author":"Imazio","year":"2017","journal-title":"Rev M\u00e9decine Interne 1 mai"},{"issue":"4","key":"10.1016\/j.autrev.2019.04.001_bb0140","doi-asserted-by":"crossref","first-page":"263","DOI":"10.2459\/JCM.0000000000000260","article-title":"Intravenous human immunoglobulins for refractory recurrent pericarditis: a systematic review of all published cases","volume":"17","author":"Imazio","year":"2016","journal-title":"J Cardiovasc Med (Hagerstown)"},{"issue":"3","key":"10.1016\/j.autrev.2019.04.001_bb0145","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1378\/chest.12-1728","article-title":"Methotrexate vs azathioprine in second-line therapy of sarcoidosis","volume":"144","author":"Vorselaars","year":"2013","journal-title":"Chest"},{"issue":"9","key":"10.1016\/j.autrev.2019.04.001_bb0150","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1093\/rheumatology\/39.9.975","article-title":"Meta-analysis of treatment termination rates among rheumatoid arthritis patients receiving disease-modifying anti-rheumatic drugs","volume":"39","author":"Maetzel","year":"2000","journal-title":"Rheumatol Oxf Engl sept"},{"issue":"26","key":"10.1016\/j.autrev.2019.04.001_bb0155","doi-asserted-by":"crossref","first-page":"2790","DOI":"10.1056\/NEJMoa0802311","article-title":"Azathioprine or methotrexate maintenance for ANCA-associated Vasculitis","volume":"359","author":"Pagnoux","year":"2008","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.autrev.2019.04.001_bb0160","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1136\/annrheumdis-2016-210882","article-title":"Enteric-coated mycophenolate sodium versus azathioprine in patients with active systemic lupus erythematosus: a randomised clinical trial","volume":"76","author":"Ordi-Ros","year":"2017","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"10.1016\/j.autrev.2019.04.001_bb0165","doi-asserted-by":"crossref","first-page":"661","DOI":"10.2165\/00003495-200565050-00006","article-title":"Efficacy, tolerability and cost effectiveness of disease-modifying antirheumatic drugs and biologic agents in rheumatoid arthritis","volume":"65","author":"Nurmohamed","year":"2005","journal-title":"Drugs."},{"issue":"2","key":"10.1016\/j.autrev.2019.04.001_bb0170","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/j.1365-2249.2009.04079.x","article-title":"Economic evaluation of immunoglobulin replacement in patients with primary antibody deficiencies","volume":"160","author":"Beaut\u00e9","year":"2010","journal-title":"Clin Exp Immunol mai"},{"issue":"4","key":"10.1016\/j.autrev.2019.04.001_bb0175","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S0735-1097(03)00778-2","article-title":"Recurrent pericarditis in children and adolescents: report of 15 cases","volume":"42","author":"Raatikka","year":"2003","journal-title":"J Am Coll Cardiol ao\u00fbt"},{"issue":"4","key":"10.1016\/j.autrev.2019.04.001_bb0180","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/s11739-018-1842-x","article-title":"Management of idiopathic recurrent pericarditis in adults and in children: a role for IL-1 receptor antagonism","volume":"13","author":"Brucato","year":"2018","journal-title":"Intern Emerg Med 1 juin"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997219300916?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997219300916?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T21:15:12Z","timestamp":1761599712000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997219300916"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":36,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["S1568997219300916"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2019.04.001","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Corticosteroids and immunosuppressive agents for idiopathic recurrent pericarditis","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2019.04.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}